Literature DB >> 1560527

Transformation-dependent expression of interleukin genes delivered by a recombinant parvovirus.

S J Russell1, A Brandenburger, C L Flemming, M K Collins, J Rommelaere.   

Abstract

The prototype strain of minute virus of mice [MVM(p)] is an autonomous parvovirus with a tropism for cells expressing a neoplastically transformed phenotype. To generate gene transfer vectors for tumor-specific gene expression, human interleukin-2 (IL-2) and murine interleukin-4 (IL-4) genes were cloned under the control of the p38 late promoter of MVM(p). Upon transfection into permissive cells, the recombinant MVMIL2 or MVMIL4 DNA was excised, amplified, and, in the presence of a helper plasmid, packaged into recombinant viral particles. The recombinant viruses were able to transfer fully functional IL-2 and IL-4 genes to permissive target cells and retained the oncotropic host range properties of the parental virus. Following infection with MVMIL2, nontransformed fibroblasts of rodent (FR3T3) or human (MRC-5) origin produced minimal IL-2 compared with the high levels of IL-2 production observed in their transformed derivatives (FREJ4 and MRC-5V1).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1560527      PMCID: PMC241039     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Limitations to the expression of parvoviral nonstructural proteins may determine the extent of sensitization of EJ-ras-transformed rat cells to minute virus of mice.

Authors:  B Van Hille; N Duponchel; N Salomé; N Spruyt; S F Cotmore; P Tattersall; J J Cornelis; J Rommelaere
Journal:  Virology       Date:  1989-07       Impact factor: 3.616

2.  Murine interleukin-4 displays potent anti-tumor activity in vivo.

Authors:  R I Tepper; P K Pattengale; P Leder
Journal:  Cell       Date:  1989-05-05       Impact factor: 41.582

3.  Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor 1 activities and T-cell- and mast-cell-stimulating activities.

Authors:  F Lee; T Yokota; T Otsuka; P Meyerson; D Villaret; R Coffman; T Mosmann; D Rennick; N Roehm; C Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

4.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

5.  Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1.

Authors:  J Ohara; W E Paul
Journal:  Nature       Date:  1985 May 23-29       Impact factor: 49.962

6.  Nonstructural protein of parvoviruses B19 and minute virus of mice controls transcription.

Authors:  C Doerig; B Hirt; J P Antonietti; P Beard
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

7.  Minute virus of mice non-structural protein NS-1 is necessary and sufficient for trans-activation of the viral P39 promoter.

Authors:  C Doerig; B Hirt; P Beard; J P Antonietti
Journal:  J Gen Virol       Date:  1988-10       Impact factor: 3.891

8.  A human parvovirus-like virus inhibits haematopoietic colony formation in vitro.

Authors:  P P Mortimer; R K Humphries; J G Moore; R H Purcell; N S Young
Journal:  Nature       Date:  1983 Mar 31-Apr 6       Impact factor: 49.962

9.  B-cell stimulatory factor 1 and not interleukin 2 is the autocrine growth factor for some helper T lymphocytes.

Authors:  A H Lichtman; E A Kurt-Jones; A K Abbas
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

10.  Influence of tumour growth on the evolution of cytotoxic lymphoid cells in rats bearing a spontaneously metastasizing syngeneic fibrosarcoma.

Authors:  G A Currie; J O Gage
Journal:  Br J Cancer       Date:  1973-08       Impact factor: 7.640

View more
  16 in total

1.  Cloning and sequencing of defective particles derived from the autonomous parvovirus minute virus of mice for the construction of vectors with minimal cis-acting sequences.

Authors:  N Clément; B Avalosse; K El Bakkouri; T Velu; A Brandenburger
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  The NS2 proteins of parvovirus minute virus of mice are required for efficient nuclear egress of progeny virions in mouse cells.

Authors:  Virginie Eichwald; Laurent Daeffler; Michèle Klein; Jean Rommelaere; Nathalie Salomé
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

3.  The infectivity and lytic activity of minute virus of mice wild-type and derived vector particles are strikingly different.

Authors:  Susanne I Lang; Stephanie Boelz; Alexandra Y Stroh-Dege; Jean Rommelaere; Christiane Dinsart; Jan J Cornelis
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 4.  Vectors for cancer gene therapy.

Authors:  J Zhang; S J Russell
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

Review 5.  New therapeutic approaches based on gene transfer techniques.

Authors:  H Chong; R G Vile
Journal:  Springer Semin Immunopathol       Date:  1996

6.  Use of an autonomous parvovirus vector for selective transfer of a foreign gene into transformed human cells of different tissue origins and its expression therein.

Authors:  F Dupont; L Tenenbaum; L P Guo; P Spegelaere; M Zeicher; J Rommelaere
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

7.  B1 lymphocytes and myeloid dendritic cells in lymphoid organs are preferential extratumoral sites of parvovirus minute virus of mice prototype strain expression.

Authors:  Zahari Raykov; Larissa Savelyeva; Ginette Balboni; Thomas Giese; Jean Rommelaere; Nathalia A Giese
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

8.  Terminal regions of the NS-1 protein of the parvovirus minute virus of mice are involved in cytotoxicity and promoter trans inhibition.

Authors:  D Legendre; J Rommelaere
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

9.  A nonproliferating parvovirus vaccine vector elicits sustained, protective humoral immunity following a single intravenous or intranasal inoculation.

Authors:  Gene A Palmer; Jennifer L Brogdon; Stephanie L Constant; Peter Tattersall
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

10.  The NS1 polypeptide of the murine parvovirus minute virus of mice binds to DNA sequences containing the motif [ACCA]2-3.

Authors:  S F Cotmore; J Christensen; J P Nüesch; P Tattersall
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.